Hemodiafiltration beyond the CONVINCE trial
Giovanni F M Strippoli, Krister Cromm, Vasileios C Pezoulas, Nikolaos Tachos, Dimitrios I Fotiadis, Allison Jaure, Jolanta Malyszko, Michael Anger, Felix Fischer, Jörgen Hegbrant, Sagar Nigwekar, Rümeyza Kazancıoğlu · 2026
Read Hemodiafiltration beyond the CONVINCE trial by Giovanni F M Strippoli, Krister Cromm, Vasileios C Pezoulas, Nikolaos Tachos, Dimitrios I Fotiadis, Allison Jaure, Jolanta Malyszko, Michael Anger, Felix Fischer, Jörgen Hegbrant, Sagar Nigwekar, Rümeyza Kazancıoğlu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13224832.txt.
Description
Online hemodiafiltration (HDF) is a dialysis modality that can improve patient outcomes beyond those achieved with conventional high-flux hemodialysis (HD) in patients with kidney failure. The CONVINCE trial, the latest and the largest of a series of randomized trials comparing HDF with HD, demonstrated a 23% reduction in the risk of all-cause mortality with high-volume HDF compared to high-flux HD.
Catalog record
| CREATOR | Giovanni F M Strippoli, Krister Cromm, Vasileios C Pezoulas, Nikolaos Tachos, Dimitrios I Fotiadis, Allison Jaure, Jolanta Malyszko, Michael Anger, Felix Fischer, Jörgen Hegbrant, Sagar Nigwekar, Rümeyza Kazancıoğlu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |